1. Home
  2. SSP vs DMAC Comparison

SSP vs DMAC Comparison

Compare SSP & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSP
  • DMAC
  • Stock Information
  • Founded
  • SSP 1878
  • DMAC 2000
  • Country
  • SSP United States
  • DMAC United States
  • Employees
  • SSP 5200
  • DMAC N/A
  • Industry
  • SSP Broadcasting
  • DMAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSP Industrials
  • DMAC Health Care
  • Exchange
  • SSP Nasdaq
  • DMAC Nasdaq
  • Market Cap
  • SSP 188.3M
  • DMAC 224.6M
  • IPO Year
  • SSP 1988
  • DMAC N/A
  • Fundamental
  • Price
  • SSP $2.21
  • DMAC $5.84
  • Analyst Decision
  • SSP Buy
  • DMAC Strong Buy
  • Analyst Count
  • SSP 2
  • DMAC 3
  • Target Price
  • SSP $5.75
  • DMAC $7.00
  • AVG Volume (30 Days)
  • SSP 619.7K
  • DMAC 100.7K
  • Earning Date
  • SSP 02-21-2025
  • DMAC 03-18-2025
  • Dividend Yield
  • SSP N/A
  • DMAC N/A
  • EPS Growth
  • SSP N/A
  • DMAC N/A
  • EPS
  • SSP N/A
  • DMAC N/A
  • Revenue
  • SSP $2,397,162,000.00
  • DMAC N/A
  • Revenue This Year
  • SSP $10.34
  • DMAC N/A
  • Revenue Next Year
  • SSP N/A
  • DMAC N/A
  • P/E Ratio
  • SSP N/A
  • DMAC N/A
  • Revenue Growth
  • SSP 1.66
  • DMAC N/A
  • 52 Week Low
  • SSP $1.68
  • DMAC $2.14
  • 52 Week High
  • SSP $9.35
  • DMAC $6.41
  • Technical
  • Relative Strength Index (RSI)
  • SSP 46.47
  • DMAC 58.38
  • Support Level
  • SSP $2.10
  • DMAC $5.25
  • Resistance Level
  • SSP $2.34
  • DMAC $6.14
  • Average True Range (ATR)
  • SSP 0.20
  • DMAC 0.38
  • MACD
  • SSP -0.02
  • DMAC 0.02
  • Stochastic Oscillator
  • SSP 11.11
  • DMAC 73.81

About SSP E.W. Scripps Company (The)

The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Share on Social Networks: